SCHEMBL31751076

SCHEMBL31751076

NCc1cc2c(N)nncc2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 8/20 0.38
▸ RHEB Q15382 1/20 0.33
▸ C1S P09871 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23478648 0.68 LOXL2 (0.39) LOXL2RHEB
Hydrochloric Acid SCHEMBL23452389 0.67 LOXL2 (0.38) LOXL2RHEB
SCHEMBL30414670 0.63 IDO1 (0.41) C1S
SCHEMBL30493103 0.59 MEN1 (0.41) C1S
SCHEMBL23474198 0.57 LOXL2 (0.50) LOXL2
SCHEMBL29560277 0.56 KDM4E (0.57) C1S
SCHEMBL600018 0.56 KDM4E (0.57) C1S
SCHEMBL2056361 0.56 C1S (0.48) C1S
SCHEMBL2056363 0.56 TYMS (0.41) C1S
SCHEMBL22715522 0.56 MEN1 (0.45) C1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025264954-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2025-12-26 — — WO disclosed
Send feedback